Back to Search
Start Over
Aldo-Keto Reductases 1B in Endocrinology and Metabolism
- Source :
- Frontiers in Pharmacology, Frontiers in Pharmacology, 2012, 3, ⟨10.3389/fphar.2012.00148⟩, Frontiers in Pharmacology, Frontiers, 2012, 3, ⟨10.3389/fphar.2012.00148⟩, Frontiers in Pharmacology, Vol 3 (2012)
- Publication Year :
- 2012
- Publisher :
- HAL CCSD, 2012.
-
Abstract
- The aldose reductase (human AKR1B1/mouse Akr1b3) has been the focus of many research because of its role in diabetic complications. The starting point of these alterations is the massive entry of glucose in polyol pathway where it is converted into sorbitol by this enzyme. However, the issue of aldose reductase function in non-diabetic condition remains unresolved. Aldose reductase-like enzymes (AKR1B10, Akr1b7 and Akr1b8) are highly related isoforms often co-expressed with bona fide aldose reductase, making functional analysis of one or the other isoform a challenging task. AKR1B/Akr1b members share at least 65% protein identity and the general ability to reduce many redundant substrates such as aldehydes provided from lipid peroxidation, steroids and their by-products and xenobiotics in vitro. Based on these properties, AKR1B/Akr1b are generally considered as detoxifying enzymes. Considering that divergences should be more informative than similarities to help understanding their physiological functions, we chose to review specific hallmarks of each human/mouse isoforms by focusing on tissue distribution and specific mechanisms of gene regulation. Indeed, although the aldose reductase shows ubiquitous expression, aldose reductase-like proteins exhibit tissue-specific patterns of expression. We focused on 3 organs where certain isoforms are enriched, the adrenal gland, enterohepatic and adipose tissues and tried to connect recent enzymatic and regulation data with endocrine and metabolic functions of these organs. We presented recent mouse models showing unsuspected physiological functions in the regulation of glucido-lipidic metabolism and adipose tissue homeostasis. Beyond the widely accepted idea that AKR1B/Akr1b are detoxification enzymes, these recent reports provide growing evidences that they are able to modify or generate signal molecules. This conceptually shifts this class of enzymes from unenviable status of scavenger to upper class of messengers.
- Subjects :
- Gene isoform
medicine.medical_specialty
Adipose tissue
[SDV.CAN]Life Sciences [q-bio]/Cancer
Review Article
Biology
prostaglandins
03 medical and health sciences
0302 clinical medicine
Polyol pathway
Internal medicine
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
medicine
Pharmacology (medical)
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
chemistry.chemical_classification
Regulation of gene expression
Pharmacology
0303 health sciences
Aldose reductase
Aldo-keto reductase
aldose reductases
lcsh:RM1-950
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology
[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
adipose tissue
[SDV.GEN.GA]Life Sciences [q-bio]/Genetics/Animal genetics
Enzyme
Endocrinology
lcsh:Therapeutics. Pharmacology
[SDV.BDD.EO]Life Sciences [q-bio]/Development Biology/Embryology and Organogenesis
chemistry
Biochemistry
Aldose
030220 oncology & carcinogenesis
enterohepatic tissue
metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 16639812
- Database :
- OpenAIRE
- Journal :
- Frontiers in Pharmacology, Frontiers in Pharmacology, 2012, 3, ⟨10.3389/fphar.2012.00148⟩, Frontiers in Pharmacology, Frontiers, 2012, 3, ⟨10.3389/fphar.2012.00148⟩, Frontiers in Pharmacology, Vol 3 (2012)
- Accession number :
- edsair.doi.dedup.....e9cb41284c286816031554f2e1b3c581
- Full Text :
- https://doi.org/10.3389/fphar.2012.00148⟩